Asian Spectator

Men's Weekly

.

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

  • Written by ACN Newswire - Press Releases

Antengene Corporation Closes US$97 Million Series C Financing to Support Ongoing Drug Development and Preparations for Potential Commercialization

SHANGHAI, CHINA, Jul 20, 2020 - (ACN Newswire) - Antengene Corporation, a leading innovative hematology and oncology-focused biopharmaceutical company dedicated to discovering, developing and commercializing global first-in-class and best-in-class therapies, today announced that it has successfully closed US$97 million in Series C financing.

The...

More Articles ...

  1. Top 7 Benefits That a CBD-Rich Oil Can Potentially Offer
  2. Australians concerned about their financial wellbeing as a result of COVID-19
  3. Fivetran Raises $100 Million to Accelerate Growth as Automated Data Integration Leader
  4. Commodities Intelligence Centre (CIC) introduces international Trade Data and Business Services, partners SBF to drive digital transformation of Singapore SMEs

Magazine

Bisakah rumah flat Menteng jadi tren dan alternatif kepemilikan properti bersama tahun ini?

● Konsep rumah flat Menteng perlu mendapat perhatian pemerintah sebagai alternatif penyediaan perumahan masyarakat.● Hal ini bisa mendukung penerapan penyediaan rumah berbasis komunitas ya...

Demam durian di Cina: Dari buah tropis hingga jadi alat memuluskan diplomasi

Durian adalah buah tropis asal Asia Tenggara yang dikenal dengan aroma sangat kuat dan menyengat.passkphoto / ShutterstockDengan cita rasa yang khas dan reputasi yang kerap menuai perdebatan, durian b...

Rupiah di Titik Nadir: Tanda Bahaya atau Gejolak Sementara?

Rupiah di Titik Nadir: Tanda Bahaya atau Gejolak Sementara?Robert Lens/PexelsAwal tahun 2026 disambut dengan pertanyaan besar oleh banyak pihak. Bukan tanpa alasan, nilai tukar Rupiah terhadap Dolar A...